Records containing: Non-small Cell Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-03-05Salvage Therapy With Docetaxel and Blueberry Powder in Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-02-28ClinicalTrials.gov study NCT01102517
-
CLINICAL_TRIALS study record update · 2018-02-27A Phase-1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-02-26Randomized, Multicenter, Phase III, Open-Label Study of Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase-Positive Advanced Non Small Cell Lung Cancer Patients Previously Treated With Platinum-Based Chemotherapy and Crizotinib
-
CLINICAL_TRIALS study record update · 2018-02-20Whether 18F-ALF-NOTA-PRGD2 PET/CT Scan Can Predict the Efficacy and Adverse Events of Apatinib in Patients With Malignancies.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-02-07A Phase 1b/Adaptive Phase 2 Study of Docetaxel With or Without MLN1117 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-02-06ClinicalTrials.gov study NCT02784158
-
CLINICAL_TRIALS study record update · 2018-01-31A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-01-31Identification of Acute Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy With Advanced Multi-modality Imaging (RICT-LUNG)
-
CLINICAL_TRIALS study record update · 2018-01-23A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-01-23Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Two-Part Study of Patritumab (U3-1287) In Combination With Erlotinib in EGFR Wild-type Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Who Have Progressed on at Least One Prior Systemic Therapy
-
CLINICAL_TRIALS study record update · 2018-01-17Phase 1 Study of Mifepristone in Combination With Eribulin in Patients With Locally Advanced/Metastatic Breast or Other Specified Solid Tumors, With a Dose Expansion Cohort in Patients With Triple Negative Breast Cancer.
-
CLINICAL_TRIALS study record update · 2018-01-16The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation: A Phase II Single Arm Prospective Study
-
CLINICAL_TRIALS study record update · 2017-12-15Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer.
-
CLINICAL_TRIALS study record update · 2017-12-06Identification of Tumor Neoantigens During Immune Checkpoint Blockade in Resectable Non-Small Cell Lung Cancer (NSCLC)
-
CLINICAL_TRIALS study record update · 2017-11-21A Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of Volociximab (M200) in Combination With Carboplatin and Paclitaxel in Subjects With Previously Untreated Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC)
-
CLINICAL_TRIALS study record update · 2017-11-13The Randomized,Open, Multicenter Phase III Study to Compare the Effectiveness and Safety of Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin First-Line Therapy Advanced Non Small Cell Lung Cancer Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2017-11-09A Open Multicenter Clinical Study to Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI (Unique Molecular Identifier) Technology of Burning Rock
-
CLINICAL_TRIALS study record update · 2017-11-06A Phase II Randomized Study of Nab-paclitaxel With Gemcitabine at Two Different Dose Combinations to Determine Efficacy in Patients With Advanced Non- Squamous Non-small Cell Lung Cancer (NSCLC).
-
CLINICAL_TRIALS study record update · 2017-10-13Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention
-
CLINICAL_TRIALS study record update · 2017-09-26Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET
-
CLINICAL_TRIALS study record update · 2017-09-25A Phase 1/2 Safety and Efficacy Study of Natural Killer and Natural Killer T Cell Immunotherapy in Patients With Non Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-09-18A Registered Randomized, Double-Blind, Placebo-Controlled (2:1), Multi-Centered Clinical Trial of Anlotinib as a Treatment for Advanced Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-09-14Treatment of Non-small Cell Lung Cancer With CIK Cells Blocked by PD-1 Antibody
-
CLINICAL_TRIALS study record update · 2017-09-05A Phase 1 Multi Arm Study Evaluating the Safety, Pharmacology and Preliminary Activity of the Co-Administration of MM-151 With Seribantumab (MM-121), Istiratumab (MM-141), or Trametinib in Biomarker-selected Cancer Patients